Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Upgrades Zymeworks to Outperform

SVB Leerink analyst Andrew Berens upgrades Zymeworks (NYSE:ZYME) from Market Perform to Outperform.

byBenzinga Newsdesk

December 10, 2021

1 minute read

SVB Leerink analyst Andrew Berens upgrades Zymeworks (NYSE:ZYME) from Market Perform to Outperform.

Morgan Stanley Maintains Equal-Weight on Archer-Daniels Midland, Raises Price Target to $69

By Benzinga Newsdesk

Today, 4:36 AM

Morgan Stanley analyst Vincent Andrews maintains Archer-Daniels Midland (NYSE:ADM) with a Equal-Weight and raises the price target from $67 to $69.

ADM

Amid Spending Constraints, Hashi Should Top List On Substantial Discount Over Microsoft, Amazon, Google Clouds: Analyst

By Anusuya Lahiri

Today, 4:36 AM

Needham analyst Alex Henderson maintained a Hold on HashiCorp, Inc (NASDAQ:HCP). Hashi demonstrated demand resilience against macro headwinds posting strong 52% Q3…

AMZN

A Look Into iStar’s Price Over Earnings

By Benzinga Insights

Today, 4:36 AM

STAR

Analyst Ratings

Analyst Ratings for VIZIO Holding

By Benzinga Insights

Today, 4:36 AM

Analysts have provided the following ratings for VIZIO Holding (NYSE:VZIO) within the last quarter:

VZIO

SVB Leerink Upgrades Zymeworks to Outperform

Related Posts

Morgan Stanley Maintains Equal-Weight on Archer-Daniels Midland, Raises Price Target to $69

Amid Spending Constraints, Hashi Should Top List On Substantial Discount Over Microsoft, Amazon, Google Clouds: Analyst

A Look Into iStar’s Price Over Earnings

Analyst Ratings for VIZIO Holding